XOMA (XOMA)
(Real Time Quote from BATS)
$25.33 USD
+0.30 (1.20%)
Updated May 21, 2024 02:48 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
XOMA 25.33 +0.30(1.20%)
Will XOMA be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for XOMA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XOMA
Certara, Inc. (CERT) Q1 Earnings Meet Estimates
Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
XOMA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Lexicon Pharmaceuticals (LXRX) Reports Q1 Loss, Misses Revenue Estimates
Xoma (XOMA) Moves 7.7% Higher: Will This Strength Last?
Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
Other News for XOMA
Brookline upgrades Dare Bioscience to Buy on improved funding
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
Buy Rating Affirmed for Xoma with Enhanced Price Target Reflecting New Royalty Assets and Growth Prospects
XOMA Corp (XOMA) Q1 2024 Earnings: Misses Revenue Estimates, Reports Lower Net Loss
XOMA Stock Earnings: XOMA Misses EPS, Beats Revenue for Q1 2024